NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	25/08/2016
Target sample size	60
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : epacadostat Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : pembrolizumab,epacadostat Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : pembrolizumab,epacadostat,cisplatin,pemetrexed Therapeutic category code : 42- Antineoplastic agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : pembrolizumab,epacadostat,carboplatin,pemetrexed Therapeutic category code : 42- Antineoplastic agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : pembrolizumab,epacadostat,carboplatin,paclitaxel Therapeutic category code : 42- Antineoplastic agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	safety
Secondary Outcome	other

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria